HHS to Continue 340B “Orphan” Drug Rule
Wednesday, July 2, 2014
In July 2013 the U.S. Department of Health and Human Services (HHS)issued a final regulation allowing 340B covered entities (public safety-net health providers) to purchase orphan drugs at the discounted 340B prices even when the drugs aren’t used to treat the rare disease or condition for which the drug obtained orphan status. However, in May […]